SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Constellation Brands, Inc. – ‘10-Q’ for 11/30/19 – ‘EX-10.6’

On:  Wednesday, 1/8/20, at 12:21pm ET   ·   For:  11/30/19   ·   Accession #:  16918-20-7   ·   File #:  1-08495

Previous ‘10-Q’:  ‘10-Q’ on 10/3/19 for 8/31/19   ·   Next:  ‘10-Q’ on 7/1/20 for 5/31/20   ·   Latest:  ‘10-Q’ on 1/5/24 for 11/30/23   ·   1 Reference:  By:  Constellation Brands, Inc. – ‘8-K’ on 10/2/20 for 9/30/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/08/20  Constellation Brands, Inc.        10-Q       11/30/19  106:23M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   3.10M 
 2: EX-10.6     Material Contract                                   HTML     31K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
45: R1          Cover Page                                          HTML     86K 
101: R2          Consolidated Balance Sheets (Unaudited)             HTML    134K  
64: R3          Consolidated Balance Sheets (Unaudited)             HTML     39K 
                (Parenthetical)                                                  
31: R4          Consolidated Statements of Comprehensive Income     HTML    120K 
                (Loss) (Unaudited)                                               
46: R5          Consolidated Statements of Changes in               HTML    107K 
                Stockholders' Equity (Unaudited)                                 
102: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    145K  
65: R7          Basis of Presentation                               HTML     31K 
34: R8          Accounting Guidance                                 HTML     32K 
43: R9          Inventories                                         HTML     42K 
92: R10         Business Transformation                             HTML    106K 
80: R11         Derivative Instruments                              HTML    180K 
22: R12         Fair Value of Financial Instruments                 HTML    217K 
58: R13         Goodwill                                            HTML     59K 
93: R14         Intangible Assets                                   HTML     57K 
81: R15         Equity Method Investments                           HTML    102K 
23: R16         Other Assets                                        HTML     36K 
59: R17         Borrowings                                          HTML    127K 
94: R18         Income Taxes                                        HTML     37K 
79: R19         Deferred Income Taxes and Other Liabilities         HTML     40K 
25: R20         Leases                                              HTML    187K 
35: R21         Stockholders' Equity                                HTML    190K 
98: R22         Net Income (Loss) Per Common Share Attributable to  HTML    115K 
                CBI                                                              
60: R23         Comprehensive Income (Loss) Attributable to CBI     HTML    223K 
26: R24         Condensed Consolidating Financial Information       HTML    832K 
36: R25         Business Segment Information                        HTML    289K 
99: R26         Basis of Presentation (Policies)                    HTML     30K 
61: R27         Accounting Guidance (Policies)                      HTML     31K 
24: R28         Inventories (Tables)                                HTML     40K 
37: R29         Business Transformation (Tables)                    HTML    104K 
57: R30         Derivative Instruments (Tables)                     HTML    179K 
20: R31         Fair Value of Financial Instruments (Tables)        HTML    211K 
83: R32         Goodwill (Tables)                                   HTML     56K 
96: R33         Intangible Assets (Tables)                          HTML     87K 
56: R34         Equity Method Investments (Tables)                  HTML    132K 
19: R35         Other Assets (Tables)                               HTML     36K 
82: R36         Borrowings (Tables)                                 HTML    112K 
95: R37         Deferred Income Taxes and Other Liabilities         HTML     39K 
                (Tables)                                                         
55: R38         Leases (Tables)                                     HTML    127K 
21: R39         Stockholders' Equity (Tables)                       HTML    190K 
47: R40         Net Income (Loss) Per Common Share Attributable to  HTML    111K 
                CBI (Tables)                                                     
32: R41         Comprehensive Income (Loss) Attributable to CBI     HTML    224K 
                (Tables)                                                         
66: R42         Condensed Consolidating Financial Information       HTML    830K 
                (Tables)                                                         
103: R43         Business Segment Information (Tables)               HTML    284K  
44: R44         Accounting Guidance (Details)                       HTML     34K 
30: R45         Inventories (Details)                               HTML     41K 
63: R46         Business Transformation (Details)                   HTML     47K 
100: R47         Business Transformation (Details 1)                 HTML     91K  
42: R48         Business Transformation (Details 2)                 HTML     46K 
33: R49         Business Transformation (Details Textual)           HTML     57K 
17: R50         Derivative Instruments (Details)                    HTML     38K 
52: R51         Derivative Instruments (Details 1)                  HTML     60K 
84: R52         Derivative Instruments (Details 2)                  HTML     58K 
70: R53         Derivative Instruments (Details Textual)            HTML     32K 
18: R54         Fair Value of Financial Instruments (Details)       HTML     93K 
53: R55         Fair Value of Financial Instruments (Details 1)     HTML    104K 
85: R56         Fair Value of Financial Instruments (Details 2)     HTML     59K 
71: R57         Fair Value of Financial Instruments (Details        HTML     41K 
                Textual)                                                         
16: R58         Fair Value of Financial Instruments (Details        HTML     73K 
                Textual 1)                                                       
54: R59         Goodwill (Details)                                  HTML     47K 
104: R60         Goodwill (Details Textual)                          HTML     37K  
68: R61         Intangible Assets (Details)                         HTML     46K 
28: R62         Equity Method Investments (Details)                 HTML     57K 
39: R63         Equity Method Investments (Details 1)               HTML     58K 
105: R64         Equity Method Investments (Details Textual)         HTML    127K  
69: R65         Other Assets (Details)                              HTML     32K 
29: R66         Borrowings (Details)                                HTML    106K 
41: R67         Borrowings (Details 1)                              HTML     50K 
106: R68         Borrowings (Details Textual)                        HTML     88K  
67: R69         Income Taxes (Details Textual)                      HTML     32K 
76: R70         Deferred Income Taxes and Other Liabilities         HTML     39K 
                (Details)                                                        
91: R71         Leases (Details)                                    HTML     54K 
51: R72         Leases (Details 1)                                  HTML     42K 
15: R73         Leases (Details 2)                                  HTML     71K 
72: R74         Leases (Details 3)                                  HTML     47K 
88: R75         Leases (Details 4)                                  HTML     49K 
48: R76         Leases (Details Textual)                            HTML     27K 
12: R77         Stockholders' Equity (Details)                      HTML    129K 
78: R78         Stockholders' Equity (Details 1)                    HTML     42K 
87: R79         Stockholders' Equity (Details Textual)              HTML     42K 
75: R80         Net Income (Loss) Per Common Share Attributable to  HTML     74K 
                CBI (Details)                                                    
90: R81         Net Income (Loss) Per Common Share Attributable to  HTML     31K 
                CBI (Details Textual)                                            
50: R82         Comprehensive Income (Loss) Attributable to CBI     HTML    109K 
                (Details)                                                        
14: R83         Comprehensive Income (Loss) Attributable to CBI     HTML     74K 
                (Details 1)                                                      
74: R84         Condensed Consolidating Financial Information       HTML    221K 
                (Details)                                                        
89: R85         Condensed Consolidating Financial Information       HTML    162K 
                (Details 1)                                                      
49: R86         Condensed Consolidating Financial Information       HTML    154K 
                (Details 2)                                                      
13: R87         Business Segment Information (Details)              HTML     91K 
77: R88         Business Segment Information (Details 1)            HTML    104K 
86: R89         Business Segment Information (Details Textual)      HTML     29K 
27: R9999       Uncategorized Items - stz1130201910q.htm            HTML     44K 
40: XML         IDEA XML File -- Filing Summary                      XML    196K 
38: XML         XBRL Instance -- stz1130201910q_htm                  XML   8.22M 
97: EXCEL       IDEA Workbook of Financial Reports                  XLSX    141K 
 8: EX-101.CAL  XBRL Calculations -- stz-20191130_cal                XML    390K 
 9: EX-101.DEF  XBRL Definitions -- stz-20191130_def                 XML   1.31M 
10: EX-101.LAB  XBRL Labels -- stz-20191130_lab                      XML   2.11M 
11: EX-101.PRE  XBRL Presentations -- stz-20191130_pre               XML   1.60M 
 7: EX-101.SCH  XBRL Schema -- stz-20191130                          XSD    190K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              476±   688K 
73: ZIP         XBRL Zipped Folder -- 0000016918-20-000007-xbrl      Zip    567K 


‘EX-10.6’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 10.6

Description of Compensation Arrangements for Non-Management Directors
As of January 1, 2020

The following is a description of the compensation arrangements for the non-management directors of Constellation Brands, Inc. The Company’s annual compensation program for non-management directors for their service as directors consists of a board cash retainer, a lead director cash retainer, chair fees, restricted stock units, non-qualified stock options, an annual product allowance, and a matching charitable contribution program.

The board cash retainer consists of an annual retainer equal to $100,000 paid in quarterly installments. The lead director cash retainer consists of a $25,000 annual cash retainer to be paid to the Board’s lead director, if any, payable in quarterly installments. The chair fees consist of annual fees of $20,000 for the positions of Chair of the Audit Committee and Chair of the Human Resources Committee, and $15,000 for the Chair of the Corporate Governance Committee, which are paid in quarterly installments.

Long-term incentive awards in the form of stock options and restricted stock units granted under the Company’s Long-Term Stock Incentive Plan are another element of non-management director compensation. As approved by the Board of Directors, each non-management director receives the following annually:

1.
A non-qualified stock option grant with a grant date fair value of $55,000 computed in accordance with FASB ASC Topic 718.

2.
A restricted stock unit award with a grant date fair value of $102,500. (Each restricted stock unit is to represent a contingent right to receive one share of the Company's Class A Common Stock.)

While the Board has the flexibility to determine at the time of each grant the vesting provisions for that grant, currently stock options vest six (6) months following the date of grant and restricted stock units vest on July 1st following the date of grant. The Long-Term Stock Incentive Plan, Amended and Restated as of July 18, 2017, is filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K dated July 18, 2017 and filed July 20, 2017.

Non-management directors are reimbursed for reasonable expenses incurred in connection with their attendance at Board and Committee meetings. They also receive an annual product allowance in the form of a $5,000 cash payment and are eligible to participate in the Company's charitable matching contribution program whereby they can direct all or a portion of the Company’s charitable matching contributions not in excess of $5,000.

Members of the Board of Directors who are members of management serve without receiving any additional fees or other compensation for their service on the Board.





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:1/8/208-K
1/1/20
For Period end:11/30/19
7/20/173,  4,  8-K
7/18/173,  4,  8-K,  DEF 14A
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/02/20  Constellation Brands, Inc.        8-K:5,7,9   9/30/20   14:22M
Top
Filing Submission 0000016918-20-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 12:13:52.1pm ET